Mark Patrick Guerin - 12 Jun 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: CFO AND COO
Signature: /s/ Mark Guerin
Issuer symbol: TRAW
Transactions as of: 12 Jun 2023
Net transactions value: -$1,791
Form type: 4
Filing time: 13 Jun 2023, 16:54:25 UTC
Previous filing: 14 Mar 2023
Next filing: 04 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+5,500	+30%		23,691	12 Jun 2023	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$1,791	-1,575	-6.6%	$1.14	22,116	12 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-5,500	-33%	$0.000000	11,000	12 Jun 2023	Common Stock	5,500		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.